CF
AZN icon

Corebridge Financial’s AstraZeneca AZN Stock Holding History

Corebridge Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,341
Closed -$2.7M – 294
2025
Q1 		$2.7M Sell
18,341
-593
-3% -$85.8K 0.02% 880
2024
Q4 		$2.48M Sell
18,934
-103
-0.5% -$14.4K 0.01% 938
2024
Q3 		$2.97M Sell
19,037
-348
-2% -$56.2K 0.02% 898
2024
Q2 		$3.02M Buy
+19,385
New +$2.92M 0.02% 874

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corebridge Financial's AZN Position: Q2 2025 in Review

Corebridge Financial sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 18,341 shares — an estimated $2.7M sold.

Corebridge Financial first reported a position in AZN in Q2 2024 and held it in 4 quarters. The position peaked at $3.02M in Q2 2024. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Corebridge Financial reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 18,341 AstraZeneca shares in Q2 2025, an estimated $2.7M.
  • Corebridge Financial first reported a position in AstraZeneca in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's AstraZeneca position peaked at $3.02M in Q2 2024.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.